Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Consumers Union supplement survey

This article was originally published in The Tan Sheet

Executive Summary

Nine in 10 consumers want dietary supplements to be proven safe and effective before being marketed, according to a new survey announced June 7 by Consumer Reports publisher Consumers Union. The random sample online survey of 1,221 adults also found that 96% of patients feel supplement makers should be required to report health problems caused by their products and label them with risk information. Eight in 10 respondents agreed that "poor regulation posed a risk to their and their family's health" while only 19% felt supplements are "sufficiently regulated." CR recently published an article naming 12 supplements the "dirty dozen" that consumers should avoid (1"The Tan Sheet" April 5, 2004, p. 13)...
Advertisement

Related Content

Consumer Reports Article Highlights “Dangerous” Supplements
Consumer Reports Article Highlights “Dangerous” Supplements

Topics

Advertisement
UsernamePublicRestriction

Register

PS096927

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel